Some of these kinases have been implicated in cancer, such as mutant forms of the receptor tyrosine kinases FLT3 and DDR2, which have been identified in acute myeloid leukemia and lung cancer, respectively 19, 20. Here, FLT3 is linked to acute myeloid leukemia.